Ryan K. Schmocker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ryan K. Schmocker has a total of 477 co-authors. Here are the top co-authors by number of shared publications:
- Emily R. Winslow
University of Wisconsin School of Medicine and Public Health, Madison, WI
6 shared publications Linda M. Cherney Stafford
Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison
5 shared publicationsGlen E. Leverson
Department of Surgery, University of Wisconsin Clinical Science Center, University of Wisconsin, 600 Highland Avenue, Madison, WI 53792, USA
3 shared publicationsAnuoluwapo F. Elegbede
Department of Surgery, Division of General Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
2 shared publications- Jacob A. Greenberg
Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
2 shared publications James M. McLoughlin
Division of Surgical Oncology, University of Tennessee Medical Center, Knoxville, TN, USA
2 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Elsevier in Surgical Oncology
- Vol. 69
International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot
- 26 October 2026
- Published by Elsevier in Surgical Oncology
- Vol. 69
Open AccessInternational survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot
- 29 March 2024
- Published by SAGE Publications in The American Surgeon™
- Vol. 91 (9) , 1430-1438
Further Distance From Treating Facility is Associated With Advanced Colon Cancer at Presentation and Increased Mortality
Background: Colon cancer outcomes in the United States have improved over the last thirty years. However, there remain significant outcome disparities, especially in rural regions. It is unclear if distance to the treating facility has an independent effect on colon cancer mortality and outcomes. We sought to evaluate whether distance from a treating facility impacts stage at diagnosis and mortality. Methods: The National Cancer Database (NCDB) was utilized to identify a cohort of adult patients with colon cancer between the years 2013 and 2017 in all regions of the United States. Outcomes measured included colon cancer TNM stage, time to surgery, time to chemotherapy, and overall survival. Results: A total of n = 356,189 patients met inclusion criteria. When controlling for race, education status, insurance status, comorbidities, and income, distance from the treating facility was a significant predictor of stage at presentation with more advanced clinical TNM stage as distance increased (AORs 1.12-1.62, P < .001 for all groups). Longer distance significantly increased the time to surgery (between 5.06 and 14.46 days, P < .001) and overall mortality (HR 1.11-1.28, P < .001). Median survival was 82.4 months for the closest group, versus 75.1 months for the farthest group ( P < .001). Conclusions: Increased distance from the treating facility resulted in a significantly higher stage at presentation, increased time to surgery, and increased mortality. These results suggest that there are significant disparities in access to cancer care for patients who live in rural areas. Targeted interventions by treating facilities are needed to improve screening and timely treatment for rural colon cancer patients.
- 29 March 2024
- Published by SAGE Publications in The American Surgeon™
- Vol. 91 (9) , 1430-1438
Further Distance From Treating Facility is Associated With Advanced Colon Cancer at Presentation and Increased Mortality
Background: Colon cancer outcomes in the United States have improved over the last thirty years. However, there remain significant outcome disparities, especially in rural regions. It is unclear if distance to the treating facility has an independent effect on colon cancer mortality and outcomes. We sought to evaluate whether distance from a treating facility impacts stage at diagnosis and mortality. Methods: The National Cancer Database (NCDB) was utilized to identify a cohort of adult patients with colon cancer between the years 2013 and 2017 in all regions of the United States. Outcomes measured included colon cancer TNM stage, time to surgery, time to chemotherapy, and overall survival. Results: A total of n = 356,189 patients met inclusion criteria. When controlling for race, education status, insurance status, comorbidities, and income, distance from the treating facility was a significant predictor of stage at presentation with more advanced clinical TNM stage as distance increased (AORs 1.12-1.62, P < .001 for all groups). Longer distance significantly increased the time to surgery (between 5.06 and 14.46 days, P < .001) and overall mortality (HR 1.11-1.28, P < .001). Median survival was 82.4 months for the closest group, versus 75.1 months for the farthest group ( P < .001). Conclusions: Increased distance from the treating facility resulted in a significantly higher stage at presentation, increased time to surgery, and increased mortality. These results suggest that there are significant disparities in access to cancer care for patients who live in rural areas. Targeted interventions by treating facilities are needed to improve screening and timely treatment for rural colon cancer patients.
- 28 February 2023
- Published by SAGE Publications in The American Surgeon™
- Vol. 89 (7) , 3192-3199
A Novel Preoperative Patient Survey Predicts Adverse Patient Outcomes—Implementation and Preliminary Results of the Tennessee Preoperative Assessment Tool
Background: Accurate preoperative risk stratification remains elusive. Existing tools are often missing important patient-reported and functional factors. We sought to implement a novel tool, with dynamic functional data and comorbidity variables, to define factors which predict postoperative outcomes. Materials and Methods: We expanded a previously validated functional questionnaire to create the Tennessee Preoperative Assessment Tool (TPAT). Unique elements included change in functional status, usual and best activity tolerance, and development of new conditions. The survey was administered to all new patients seen in several surgery clinics from July 2021 to June 2022. Results: A total of 1950 patients completed the survey. Of the completed surveys, 197 patients underwent an elective, inpatient, abdominal surgery and were included in the study. Several patient-reported factors were associated with poor postoperative outcomes. For example, decrease in functional activity in the previous 60 days (n = 50; 25.4%) was a strong predictor of poor postoperative outcomes including readmission (30-day: 8.8% vs .0%; P = .034), wound dehiscence (12.0% vs 3.4%; P = .022), blood transfusion (6.0% vs .0%; P = .003), sepsis (4.0% vs .0%; P = .015), and wound infection (18.0% vs 6.8%; P = .076). Discussion: In this preliminary implementation study, patients undergoing elective, inpatient, abdominal surgery, utilization of a novel, patient-reported survey tool proactively identifies patients at risk of clinically relevant postoperative outcomes. Patient-reported decreased activity in the 60 days prior to surgeon evaluation was associated with several adverse postoperative outcomes. Additionally, this study demonstrates that the TPAT can be seamlessly integrated into the usual clinical workflow and is hypothesis generating for future interventional studies.
- 28 February 2023
- Published by SAGE Publications in The American Surgeon™
- Vol. 89 (7) , 3192-3199
A Novel Preoperative Patient Survey Predicts Adverse Patient Outcomes—Implementation and Preliminary Results of the Tennessee Preoperative Assessment Tool
Background: Accurate preoperative risk stratification remains elusive. Existing tools are often missing important patient-reported and functional factors. We sought to implement a novel tool, with dynamic functional data and comorbidity variables, to define factors which predict postoperative outcomes. Materials and Methods: We expanded a previously validated functional questionnaire to create the Tennessee Preoperative Assessment Tool (TPAT). Unique elements included change in functional status, usual and best activity tolerance, and development of new conditions. The survey was administered to all new patients seen in several surgery clinics from July 2021 to June 2022. Results: A total of 1950 patients completed the survey. Of the completed surveys, 197 patients underwent an elective, inpatient, abdominal surgery and were included in the study. Several patient-reported factors were associated with poor postoperative outcomes. For example, decrease in functional activity in the previous 60 days (n = 50; 25.4%) was a strong predictor of poor postoperative outcomes including readmission (30-day: 8.8% vs .0%; P = .034), wound dehiscence (12.0% vs 3.4%; P = .022), blood transfusion (6.0% vs .0%; P = .003), sepsis (4.0% vs .0%; P = .015), and wound infection (18.0% vs 6.8%; P = .076). Discussion: In this preliminary implementation study, patients undergoing elective, inpatient, abdominal surgery, utilization of a novel, patient-reported survey tool proactively identifies patients at risk of clinically relevant postoperative outcomes. Patient-reported decreased activity in the 60 days prior to surgeon evaluation was associated with several adverse postoperative outcomes. Additionally, this study demonstrates that the TPAT can be seamlessly integrated into the usual clinical workflow and is hypothesis generating for future interventional studies.
- 30 October 2020
- Published by Wiley in Journal of Surgical Oncology
- Vol. 123 (2) , 416-424
Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin
Background: Periampullary neuroendocrine tumors (NETs) arise from the duodenum, ampulla, and periampullary pancreas. Duodenal and ampullary NETs are rare and may have distinct biologic behavior from pancreatic NETs (P‐NETs). We examined the outcomes of these entities.Methods: An institutional database was queried for patients undergoing resection for pancreatic head, duodenal, or ampullary NETs from 2000 to 2018. Patients with MEN1 syndrome or follow up less than 12 months were excluded.Results: Three hundred and ten patients were identified. Tumor locations were ampulla (n = 15), duodenum (n = 35) and pancreas (n = 260). Median follow‐up and recurrence‐free survival (RFS) were 60.9 (interquartile range [IQR]: 34.8–99.3) and 171.7 (IQR: 84.0–NR) months. Clinicopathologic data and survival outcomes were similar for duodenal and ampullary NETs (RFS: p = .347 and overall survival [OS]: p = .246) and were combined into an intestinal subtype (IS) group. There were no differences in OS or RFS when comparing IS‐NET and P‐NET. On multivariate analysis, tissue of origin was not associated with risk of recurrence. The current American Joint Committee on Cancer staging guidelines, which account for origin tissue, were predictive of outcomes for all subtypes.Conclusion: Tissue of origin does not appear to impact long‐term outcomes when comparing IS‐NETs and P‐NETs. The AJCC staging system offers good discriminatory capacity in the context of the tissue type.
- 30 October 2020
- Published by Wiley in Journal of Surgical Oncology
- Vol. 123 (2) , 416-424
Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin
Background: Periampullary neuroendocrine tumors (NETs) arise from the duodenum, ampulla, and periampullary pancreas. Duodenal and ampullary NETs are rare and may have distinct biologic behavior from pancreatic NETs (P‐NETs). We examined the outcomes of these entities.Methods: An institutional database was queried for patients undergoing resection for pancreatic head, duodenal, or ampullary NETs from 2000 to 2018. Patients with MEN1 syndrome or follow up less than 12 months were excluded.Results: Three hundred and ten patients were identified. Tumor locations were ampulla (n = 15), duodenum (n = 35) and pancreas (n = 260). Median follow‐up and recurrence‐free survival (RFS) were 60.9 (interquartile range [IQR]: 34.8–99.3) and 171.7 (IQR: 84.0–NR) months. Clinicopathologic data and survival outcomes were similar for duodenal and ampullary NETs (RFS: p = .347 and overall survival [OS]: p = .246) and were combined into an intestinal subtype (IS) group. There were no differences in OS or RFS when comparing IS‐NET and P‐NET. On multivariate analysis, tissue of origin was not associated with risk of recurrence. The current American Joint Committee on Cancer staging guidelines, which account for origin tissue, were predictive of outcomes for all subtypes.Conclusion: Tissue of origin does not appear to impact long‐term outcomes when comparing IS‐NETs and P‐NETs. The AJCC staging system offers good discriminatory capacity in the context of the tissue type.
- 8 March 2017
- Published by Elsevier in Journal of Surgical Research
- Vol. 215, 1-5
Disease severity and treatment does not affect satisfaction in diverticulitis
- 8 March 2017
- Published by Elsevier in Journal of Surgical Research
- Vol. 215, 1-5
Disease severity and treatment does not affect satisfaction in diverticulitis
- 1 August 2016
- Published by Elsevier in The American Journal of Surgery
- Vol. 212 (2) , 282-288
The number of inpatient consultations is negatively correlated with patient satisfaction in patients with prolonged hospital stays
- 1 August 2016
- Published by Elsevier in The American Journal of Surgery
- Vol. 212 (2) , 282-288
The number of inpatient consultations is negatively correlated with patient satisfaction in patients with prolonged hospital stays
- 25 March 2016
- Published by Elsevier in Journal of Surgical Research
- Vol. 203 (2) , 390-397
Outpatient air leak management after lobectomy: a CMS cost analysis
- 25 March 2016
- Published by Elsevier in Journal of Surgical Research
- Vol. 203 (2) , 390-397
Outpatient air leak management after lobectomy: a CMS cost analysis
- 1 January 2016
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 12 (1) , 4-9
Reduction of surgical site infections after laparoscopic gastric bypass with circular stapled gastrojejunostomy
- 1 January 2016
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 12 (1) , 4-9
Reduction of surgical site infections after laparoscopic gastric bypass with circular stapled gastrojejunostomy
- Open Access
- 1 January 2016
- Published by Wiley in Case Reports in Surgery
- Vol. 2016, 1-3
An Unusual Trocar Site Hernia after Prostatectomy
Trocar site hernias are rare complications after laparoscopic surgery but most commonly occur at larger trocar sites placed at the umbilicus. With increased utilization of the laparoscopic approach the incidence of trocar site hernia is increasing. We report a case of a trocar site hernia following an otherwise uncomplicated robotic prostatectomy at a 12 mm right lower quadrant port. The vermiform appendix was incarcerated within the trocar site hernia. Subsequent appendectomy and primary repair of the hernia were performed without complication.
- 1 January 2016
- Published by Wiley in Case Reports in Surgery
- Vol. 2016, 1-3
Open AccessAn Unusual Trocar Site Hernia after Prostatectomy
Trocar site hernias are rare complications after laparoscopic surgery but most commonly occur at larger trocar sites placed at the umbilicus. With increased utilization of the laparoscopic approach the incidence of trocar site hernia is increasing. We report a case of a trocar site hernia following an otherwise uncomplicated robotic prostatectomy at a 12 mm right lower quadrant port. The vermiform appendix was incarcerated within the trocar site hernia. Subsequent appendectomy and primary repair of the hernia were performed without complication.